These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 29339789)

  • 1. Exosome-mediated breast cancer chemoresistance via miR-155 transfer.
    Santos JC; Lima NDS; Sarian LO; Matheu A; Ribeiro ML; Derchain SFM
    Sci Rep; 2018 Jan; 8(1):829. PubMed ID: 29339789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosome-mediated delivery of functionally active miRNA-375-3p mimic regulate epithelial mesenchymal transition (EMT) of colon cancer cells.
    Rezaei R; Baghaei K; Amani D; Piccin A; Hashemi SM; Asadzadeh Aghdaei H; Zali MR
    Life Sci; 2021 Mar; 269():119035. PubMed ID: 33450254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
    Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
    Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal release of microRNA-454 by breast cancer cells sustains biological properties of cancer stem cells via the PRRT2/Wnt axis in ovarian cancer.
    Wang L; He M; Fu L; Jin Y
    Life Sci; 2020 Sep; 257():118024. PubMed ID: 32598931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes from adriamycin-resistant breast cancer cells transmit drug resistance partly by delivering miR-222.
    Yu DD; Wu Y; Zhang XH; Lv MM; Chen WX; Chen X; Yang SJ; Shen H; Zhong SL; Tang JH; Zhao JH
    Tumour Biol; 2016 Mar; 37(3):3227-35. PubMed ID: 26432333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-375 inhibits cancer stem cell phenotype and tamoxifen resistance by degrading HOXB3 in human ER-positive breast cancer.
    Fu H; Fu L; Xie C; Zuo WS; Liu YS; Zheng MZ; Yu JM
    Oncol Rep; 2017 Feb; 37(2):1093-1099. PubMed ID: 28075453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
    Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
    Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer.
    Singh R; Pochampally R; Watabe K; Lu Z; Mo YY
    Mol Cancer; 2014 Nov; 13():256. PubMed ID: 25428807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
    Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
    Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma exosome microRNAs are indicative of breast cancer.
    Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ
    Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal transfer of miR-214 mediates gefitinib resistance in non-small cell lung cancer.
    Zhang Y; Li M; Hu C
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):457-464. PubMed ID: 30458987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells.
    Yang Q; Wang Y; Lu X; Zhao Z; Zhu L; Chen S; Wu Q; Chen C; Wang Z
    Oncotarget; 2015 Feb; 6(5):3268-79. PubMed ID: 25605244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-125b regulates side population in breast cancer and confers a chemoresistant phenotype.
    Wang HJ; Guo YQ; Tan G; Dong L; Cheng L; Li KJ; Wang ZY; Luo HF
    J Cell Biochem; 2013 Oct; 114(10):2248-57. PubMed ID: 23606360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs.
    Chen WX; Liu XM; Lv MM; Chen L; Zhao JH; Zhong SL; Ji MH; Hu Q; Luo Z; Wu JZ; Tang JH
    PLoS One; 2014; 9(4):e95240. PubMed ID: 24740415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers.
    Di Modica M; Regondi V; Sandri M; Iorio MV; Zanetti A; Tagliabue E; Casalini P; Triulzi T
    Cancer Lett; 2017 Jan; 384():94-100. PubMed ID: 27693459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells.
    Zheng P; Chen L; Yuan X; Luo Q; Liu Y; Xie G; Ma Y; Shen L
    J Exp Clin Cancer Res; 2017 Apr; 36(1):53. PubMed ID: 28407783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
    Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-503-3p promotes epithelial-mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin.
    Zhao Z; Fan X; Jiang L; Xu Z; Xue L; Zhan Q; Song Y
    J Genet Genomics; 2017 Feb; 44(2):75-84. PubMed ID: 28161325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer.
    Gernapudi R; Yao Y; Zhang Y; Wolfson B; Roy S; Duru N; Eades G; Yang P; Zhou Q
    Breast Cancer Res Treat; 2015 Apr; 150(3):685-95. PubMed ID: 25783182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-200b regulates epithelial-mesenchymal transition of chemo-resistant breast cancer cells by targeting FN1.
    Yang X; Hu Q; Hu LX; Lin XR; Liu JQ; Lin X; Dinglin XX; Zeng JY; Hu H; Luo ML; Yao HR
    Discov Med; 2017 Sep; 24(131):75-85. PubMed ID: 28972876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.